… property portfolios, such as GW Pharmaceuticals (NASDAQ:GWPH). Last … alone. Chart 2. GW Pharmaceuticals (Purple) vs Alternative … GW Pharmaceutical price since IPO. (Source: Yahoo Finance … last three quarters, GW Pharmaceuticals crept closer towards …

… its IPO in May 2013, shares of cannabis drug company GW Pharmaceuticals (NASDAQ … A major innovator in cannabis GW Pharmaceuticals markets Epidolex (cannabidiol) for … its growth momentum. Meanwhile, GW Pharmaceuticals is also investigating another cannabis …

… : CureMark Yamo Pharmaceuticals GW Pharmaceuticals Zynerba Pharmaceuticals QBioMed Other … (Unaudited, interim) PXMD IPO Details PXMD intends to sell … ;s enterprise value at IPO (excluding underwriter options) … Hold for the IPO. Expected IPO Pricing Date: To …

… Pharmaceuticals, Inc. JAZZ and its GW Pharmaceuticals subsidiary announced the official initiation … . PNT (before the market open) IPOs AN2 Therapeutics, Inc., ANTX, a … infectious diseases, priced its upsized initial public offering of 4.6 million shares …

… use the proceeds from the initial public offering to develop a portfolio of … Chief Executive John Lucas cited GW Pharmaceuticals GWPRF, +9.09%, the U … the LSE, according to the IPO prospectus. Imperial Brands IMBBY, +1 …

… Medical, Inc. (NYSE: GMED) GW Pharmaceuticals plc (NASDAQ: GWPH) Medpace Holdings … trading. On The Radar IPOs Biomea Fusion, Inc., a … cancers, priced its upsized initial public offering of 9 million shares at … clinical research, priced its IPO of 6.58 million …

… plant-derived cannabinoid drug maker GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH … (before the market open) IPOs Adagene, Inc., a China- … ordinary shares, in an initial public offering. The company expects to … 7.53-million-share IPO, with the offering estimated …